Xtl Biopharmaceuticals Ltd Stock Analysis

XTL Stock Analysis Notes

The book value of the company was at this time reported as 0.01. The company recorded a loss per share of 0.03. XTL Biopharmaceuticals last dividend was issued on the 10th of February 2017. The entity had 1:5 split on the 10th of February 2017. XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. XTL Biopharmaceuticals Ltd. was incorporated in 1993 and is headquartered in Ramat Gan, Israel. Xtl Biopharma is traded on NASDAQ Exchange in the United States. For more information please call Shlomo Shalev at 972 3 611 6600 or visit https://www.xtlbio.com.

XTL Biopharmaceuticals Investment Alerts

XTL Biopharmaceuticals Upcoming and Recent Events

XTL Largest EPS Surprises

View All Earnings Estimates

XTL Stock Institutional Investors

Note, although XTL Biopharmaceutica's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

XTL Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 10.24 M.

XTL Profitablity

Management Efficiency

XTL Biopharmaceuticals has return on total asset (ROA) of (0.1378) % which means that it has lost $0.1378 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1307) %, meaning that it created substantial loss on money invested by shareholders. XTL Biopharmaceutica's management efficiency ratios could be used to measure how well XTL Biopharmaceutica manages its routine affairs as well as how well it operates its assets and liabilities. As of December 26, 2024, Return On Tangible Assets is expected to decline to -0.0009. The current year's Return On Capital Employed is expected to grow to -0.33. At present, XTL Biopharmaceutica's Other Current Assets are projected to decrease significantly based on the last few years of reporting. The current year's Net Tangible Assets is expected to grow to about 4.6 M, whereas Total Assets are forecasted to decline to about 2.3 M.

Technical Drivers

As of the 26th of December, XTL Biopharmaceutica maintains the Mean Deviation of 4.7, standard deviation of 7.53, and insignificant Risk Adjusted Performance. In relation to fundamental indicators, the technical analysis model lets you check available technical drivers of XTL Biopharmaceuticals Ltd, as well as the relationship between them.

XTL Biopharmaceuticals Price Movement Analysis

XTL Biopharmaceuticals Insider Trading Activities

XTL Biopharmaceutica Outstanding Bonds

XTL Biopharmaceutica Predictive Daily Indicators

XTL Biopharmaceutica Forecast Models

XTL Biopharmaceutica's time-series forecasting models are one of many XTL Biopharmaceutica's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary XTL Biopharmaceutica's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how XTL Biopharmaceutica prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling XTL shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as XTL Biopharmaceutica. By using and applying XTL Stock analysis, traders can create a robust methodology for identifying XTL entry and exit points for their positions.

When running XTL Biopharmaceutica's price analysis, check to measure XTL Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XTL Biopharmaceutica is operating at the current time. Most of XTL Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of XTL Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XTL Biopharmaceutica's price. Additionally, you may evaluate how the addition of XTL Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.